Natalie A Stephens1, Lauren M Sparks. 1. Translational Research Institute for Metabolism and Diabetes (N.A.S., L.M.S.), Florida Hospital, Orlando, Florida 32804; and Diabetes and Obesity Research Center (L.M.S.), Sanford-Burnham Medical Research Institute, Orlando, Florida 32827.
Abstract
CONTEXT: Exercise benefits most, but not all, individuals with type 2 diabetes (T2D). The beneficial effects are well studied, but why some individuals do not respond favorably to exercise training is largely unexplored. It is critical to treatment and prevention strategies to identify individuals with T2D that have a blunted metabolic response to exercise and investigate the underlying mechanisms that might predict this "programmed response to fail." EVIDENCE ACQUISITION: We carried out a systematic review of classic and contemporary primary reports on clinical human and animal exercise studies. We also referenced unpublished data from our previous studies, as well those of collaborators. Genetic and epigenetic components and their associations with the exercise response were also examined. EVIDENCE SYNTHESIS: As evidence of the exercise resistance premise, we and others found that supervised exercise training results in substantial response variations in glucose homeostasis, insulin sensitivity, and muscle mitochondrial density, wherein approximately 15-20% of individuals fail to improve their metabolic health with exercise. Classic genetic studies have shown that the extent of the exercise training response is largely heritable, whereas new evidence demonstrates that DNA hypomethylation is linked to the exercise response in skeletal muscle. DNA sequence variation and/or epigenetic modifications may, therefore, dictate the exercise training response. CONCLUSIONS: Studies dedicated to uncovering the mechanisms of exercise resistance will advance the field of exercise and T2D, allowing interventions to be targeted to those most likely to benefit and identify novel approaches to treat those who do not experience metabolic improvements after exercise training.
CONTEXT: Exercise benefits most, but not all, individuals with type 2 diabetes (T2D). The beneficial effects are well studied, but why some individuals do not respond favorably to exercise training is largely unexplored. It is critical to treatment and prevention strategies to identify individuals with T2D that have a blunted metabolic response to exercise and investigate the underlying mechanisms that might predict this "programmed response to fail." EVIDENCE ACQUISITION: We carried out a systematic review of classic and contemporary primary reports on clinical human and animal exercise studies. We also referenced unpublished data from our previous studies, as well those of collaborators. Genetic and epigenetic components and their associations with the exercise response were also examined. EVIDENCE SYNTHESIS: As evidence of the exercise resistance premise, we and others found that supervised exercise training results in substantial response variations in glucose homeostasis, insulin sensitivity, and muscle mitochondrial density, wherein approximately 15-20% of individuals fail to improve their metabolic health with exercise. Classic genetic studies have shown that the extent of the exercise training response is largely heritable, whereas new evidence demonstrates that DNA hypomethylation is linked to the exercise response in skeletal muscle. DNA sequence variation and/or epigenetic modifications may, therefore, dictate the exercise training response. CONCLUSIONS: Studies dedicated to uncovering the mechanisms of exercise resistance will advance the field of exercise and T2D, allowing interventions to be targeted to those most likely to benefit and identify novel approaches to treat those who do not experience metabolic improvements after exercise training.
Authors: Swaytha V Yalamanchi; Kerry J Stewart; Nan Ji; Sherita H Golden; Adrian Dobs; Diane M Becker; Dhananjay Vaidya; Brian G Kral; Rita R Kalyani Journal: Diabetes Res Clin Pract Date: 2016-10-10 Impact factor: 5.602
Authors: Sanghee Park; Kristen D Turner; Donghai Zheng; Jeffrey J Brault; Kai Zou; Alec B Chaves; Thomas S Nielsen; Charles J Tanner; Jonas T Treebak; Joseph A Houmard Journal: J Physiol Date: 2018-12-02 Impact factor: 5.182
Authors: J Matthew Hinkley; Kai Zou; Sanghee Park; Kristen Turner; Donghai Zheng; Joseph A Houmard Journal: Am J Physiol Endocrinol Metab Date: 2017-05-09 Impact factor: 4.310
Authors: Stephan Nieuwoudt; Ciarán E Fealy; Julie A Foucher; Amanda R Scelsi; Steven K Malin; Mangesh Pagadala; Michael Rocco; Bartolome Burguera; John P Kirwan Journal: Am J Physiol Endocrinol Metab Date: 2017-05-16 Impact factor: 4.310
Authors: Yann C Klimentidis; Jennifer W Bea; Patricia Thompson; Walter T Klimecki; Chengcheng Hu; Guanglin Wu; J Skye Nicholas; Kelli K Ryckman; Zhao Chen Journal: Med Sci Sports Exerc Date: 2016-07 Impact factor: 5.411
Authors: Jack A Sargeant; Stephen Bawden; Guruprasad P Aithal; Elizabeth J Simpson; Ian A Macdonald; Mark C Turner; Jessica Cegielski; Kenneth Smith; James L Dorling; Penny A Gowland; Myra A Nimmo; James A King Journal: Eur J Appl Physiol Date: 2018-02-06 Impact factor: 3.078
Authors: Lærke P Lidegaard; Anne-Louise S Hansen; Nanna B Johansen; Daniel R Witte; Søren Brage; Torsten Lauritzen; Marit E Jørgensen; Dirk L Christensen; Kristine Færch Journal: Diabetologia Date: 2015-09-05 Impact factor: 10.122